Malesia - Kiingereza - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

aft pharmaceuticals (se asia) sdn bhd - cefepime hydrochloride monohydrate -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - cefepime -

Kenya - Kiingereza - Pharmacy and Poisons Board

kopran limited c/o. surgilinks ltd parijat house, 1076, dr,e.moses road, worli, - cefepime for injection usp - powder for injection - cefepime 1000mg (as cefepime hydrochloride) - cefepime

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefepime dihydrochloride monohydrate 1 g - powder for injection - 1 g - active: cefepime dihydrochloride monohydrate 1 g excipient: arginine - indicated for the treatment of lower respiratory tract infections, including pneumonia and bronchitis, when caused by susceptible bacteria.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefepime dihydrochloride monohydrate 2 g - powder for injection - 2 g - active: cefepime dihydrochloride monohydrate 2 g excipient: arginine - indicated for the treatment of lower respiratory tract infections, including pneumonia and bronchitis, when caused by susceptible bacteria.

Panama - Kiingereza - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

vesalius pharma, s.a. - cefepime (hidrocloruro estÉril) - cefepime (hidrocloruro estÉril) ....1,00 g

Panama - Kiingereza - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

shandong luoxin pharmaceutical group stock co.,ltd - cefepime - cefepime....1.0 g

Marekani - Kiingereza - NLM (National Library of Medicine)

hospira, inc. - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime 1 g - maxipime is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of streptococcus pneumoniae , including cases associated with concurrent bacteremia, pseudomonas aeruginosa , klebsiella pneumoniae , or enterobacter species. maxipime as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studies (14.1) ]. maxipime is indicated in the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by susceptible isolates of escherichia coli or klebsiella pneumoniae , when the infection is severe, or caused by escherichia c

Marekani - Kiingereza - NLM (National Library of Medicine)

cardinal health - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime 1 g

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

omegapharm - cefepime -